|
Periodicals
| ShowHide Related Items >><< - 04/19/21
- Facebook confirms plans for 'social audio experiences'
- 04/16/21
- Facebook's Oversight Board to announce decision on Trump suspension 'soon'
- 04/15/21
- Facebook tests new tools within News Feed to recommend businesses
- 04/09/21
- Facebook removes 16,000 groups trading fake reviews, says U.K.'s CMA
- 04/15/21 Cowen
- Facebook price target raised to $360 from $350 at Cowen
- 04/13/21 Wedbush
- Facebook assumed with Neutral at Wedbush, cites privacy risk
- 04/13/21 Wedbush
- Facebook assumed at Neutral from Outperform at Wedbush
- 04/05/21 Evercore ISI
- Facebook assumed with an Outperform at Evercore ISI
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 01/27/21
- Facebook reports Q4 EPS $3.88, consensus $3.22
- 01/27/21
- Notable companies reporting after market close
- 10/29/20
- Facebook sees Q4 ad revenue growth rate higher than Q3
- 04/19/21
- Facebook working on Clubhouse-like feature, Spotify integration, CNBC says
- 04/19/21
- Facebook CEO says working with Spotify on feature to share music, Reuters says
- 04/19/21
- Facebook plans new audio products, including take on Clubhouse, Recode says
- 04/15/21
- House panel clears blueprint for big tech legislation, Reuters reports
- 04/19/21
- Fly Intel: Wall Street's top stories for Monday
- 04/14/21
- #SocialStocks: Facebook removes 16,000 trading groups with fake product reviews
- 04/14/21
- Alphabet coverage assumption, Facebook downgrade among top calls on Wall Street
- 04/07/21
- #SocialStocks: AR glasses seen as future of tech
- 03/18/21
- Facebook call volume above normal and directionally bullish
- 02/16/21
- Facebook call volume above normal and directionally bullish
- 01/27/21
- Facebook options imply 11.6% move in share price post-earnings
- 01/15/21
- Facebook call volume above normal and directionally bullish
|
|
On The Fly
|
The major averages moved… ShowHide Related Items >><< - 04/19/21
- IBM jumps over 4% to roughly $139 after upbeat Q1 results
- 04/15/21
- IBM to acquire process mining software company myInvenio
- 04/13/21
- BlackBerry and IBM established new partnership
- 04/12/21
- IBM's Independent Managed Infrastructure Services business to be named Kyndryl
- 11:57 Today
- J&J resumes COVID-19 vaccine roll-out in Europe following EMA review
- 10:15 Today
- EMA recommends clot warning for J&J vaccine, says benefit still positive
- 10:11 Today
- EMA says 'overall benefit-risk remains positive' for J&J Covid vaccine
- 10:09 Today
- EMA says blood clot warning should be added to J&J Covid vaccine
- 07:22 Today
- Travelers raises quarterly dividend 4% to 88c per share
- 06:59 Today
- Travelers raises quarterly dividend 4% to 88c per share
- 06:58 Today
- Travelers announces additional $5B share repurchase program
- 01/21/21
- Travelers reports Q4 consolidated combined ratio of 86.7%
- 08:48 Today
- P&G has started process of implementing price increases in certain categories
- 08:47 Today
- Procter & Gamble plans to return about $19B of cash to shareholders this FY
- 08:33 Today
- Procter & Gamble 'on track' to deliver top and bottom line guidance
- 04/13/21
- Procter & Gamble raises quarterly dividend 10% to 86.98c per share
- 11:20 Today
- United Airlines 'laser-focused' on paying down debt
- 11:15 Today
- United Airlines sees 'straightforward fix' for 737 MAX electric issue
- 11:10 Today
- United Airlines has identified $1.9B of $2B cost-cutting efforts
- 11:03 Today
- United Airlines has sufficient cash on hand to manage rest of pandemic
- $295.55 /
+39.22 (+15.30%) - 16:31 Today
- Canadian Pacific calls Canadian National's bid for KCS 'inferior'
- 13:16 Today
- Canadian Pacific says '405-plus' customers, stakeholders support KCS combination
- 12:36 Today
- Kansas City Southern confirms receipt of unsolicited proposal from CN
- 12:00 Today
- Kansas City Southern rises 16.0%
- 16:31 Today
- Canadian Pacific calls Canadian National's bid for KCS 'inferior'
- 12:36 Today
- Kansas City Southern confirms receipt of unsolicited proposal from CN
- 10:00 Today
- Canadian National falls -7.0%
- 09:47 Today
- Canadian National falls -7.8%
- $354.85 /
-10.33 (-2.83%) - 16:31 Today
- Canadian Pacific calls Canadian National's bid for KCS 'inferior'
- 13:16 Today
- Canadian Pacific says '405-plus' customers, stakeholders support KCS combination
- 12:36 Today
- Kansas City Southern confirms receipt of unsolicited proposal from CN
- 07:22 Today
- CN: Cash portion of deal to be funded thorugh cash on hand, $19.3B of new debt
- 13:59 Today
- Apple introduces new iPad Pro with M1 chip, 12.9-inch Liquid Retina XDR display
- 13:56 Today
- Apple says 11-inch iPad Pro starts at $799, available in second half of May
- 13:52 Today
- Apple says 12.9-inch iPad Pro comes with liquid retina XDR display
- 13:48 Today
- Apple introduces new iMac with M1 chip
- 13:43 Today
- Apple adding 5G to new iPad Pro
- 04/19/21
- Microsoft to start testing cloud gaming for Windows 10 PCs, iOS devices
- 04/16/21
- New 'Monster Hunter: Rise' was March's 2nd best-selling game in U.S., says NPD
- 04/16/21
- Video game spending grew 18% y/y to $5.6B in March, says NPD
- 09:07 Today
- Nano Dimension acquires DeepCube, to pay shareholders $40M, $30M in Nano shares
- 04/19/21
- Nano Dimension appoints Oded Gera to board of directors
- 04/08/21
- Nano Dimension appoints Gino as Chief Product Officer, head of strategic M&A
- 04/07/21
- Nano Dimension announces Zivi Nedivi appointed as new president
- $13.42 /
-5.955 (-30.74%) - 07:02 Today
- Syndax reports updated data from Phase 1 AUGMENT-101 trial of SNDX-5613
- 04/08/21
- Syndax says FDA grants Orphan Drug Designation to axatilimab
- 04/08/21
- Syndax treatment of idiopathic pulmonary fibrosis granted FDA orphan status
- 03/31/21
- Syndax's axatilimab granted Orphan Drug designation for cGVHD
- $136.22 /
-41.76 (-23.46%) - 04/19/21
- Futu Holdings drops 6% to $167.25 after 9.5M ADS offering
- 12/08/20
- Futu Holdings announces agreement to purchase shares by investment firm
- $121.66 /
+6.5302 (+5.67%) - 07:17 Today
- Crispr Therapeutics, Vertex amend collaboration for CTX001
- 04/11/21
- Crispr Therapeutics presents preclinical data on CD70 Knockout
- 02/01/21
- Crispr Therapeutics appoints Philippe Drouet as Chief Commercial Officer
- 12/21/20
- Editas leads gene editing stocks higher with 46% rally to $95.42
VRTX Vertex Pharmaceuticals - 07:17 Today
- Crispr Therapeutics, Vertex amend collaboration for CTX001
- 04/12/21
- Vertex Pharmaceuticals appoints Yvette Burton as chief people innovation officer
- 03/26/21
- Vertex Pharmaceuticals receives CHMP recommendation for Kaftrio label extension
- 03/24/21
- Vertex receives Australian G approval for TRIKAFTA
- 07:32 Today Credit Suisse
- IBM price target raised to $165 from $160 at Credit Suisse
- 07:09 Today Stifel
- IBM price target raised to $151 from $147 at Stifel
- 06:50 Today Morgan Stanley
- IBM price target raised to $152 at Morgan Stanley after Q1 results show progress
- 06:48 Today BMO Capital
- IBM price target raised to $150 from $138 at BMO Capital
- 04/19/21 Chardan
- Chardan sees J&J moving forward with Emergent if observations are minor
- 04/14/21 Guggenheim
- Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
- 04/13/21 Goldman Sachs
- J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
- 04/13/21 Morgan Stanley
- Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
- 04/01/21 Credit Suisse
- Travelers price target raised to $153 from $142 at Credit Suisse
- 03/31/21 Citi
- Travelers price target raised to $155 from $142 at Citi
- 03/24/21 Barclays
- Travelers price target raised to $165 from $155 at Barclays
- 03/12/21 MKM Partners
- Travelers price target raised to $185 from $175 at MKM Partners
- 04/16/21 JPMorgan
- Procter & Gamble price target lowered to $148 from $153 at JPMorgan
- 03/02/21 BofA
- Procter & Gamble removed from the US 1 List at BofA
- 01/28/21 Stifel
- Stifel downgrades Procter & Gamble to Hold on emerging headwinds
- 01/28/21 Stifel
- Procter & Gamble downgraded to Hold from Buy at Stifel
- 04/16/21
- Fly Intel: Top five analyst upgrades
- 04/16/21 Argus
- United Airlines upgraded to Buy on capacity and cost plans at Argus
- 04/16/21 Argus
- United Airlines upgraded to Buy from Hold at Argus
- 04/15/21 Barclays
- United Airlines price target raised to $62 from $44 at Barclays
- $295.55 /
+39.22 (+15.30%) - 04/19/21 Raymond James
- Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
- 04/19/21 Raymond James
- Kansas City Southern downgraded to Outperform from Strong Buy at Raymond James
- 04/15/21
- Fly Intel: Top five analyst downgrades
- 04/15/21 Wells Fargo
- Kansas City Southern downgraded to Equal Weight from Overweight at Wells Fargo
- 04/09/21 Scotiabank
- Canadian National price target raised to C$145 from C$140 at Scotiabank
- 03/31/21 National Bank
- Canadian National price target raised to C$147 from C$137 at National Bank
- 03/26/21 CIBC
- Canadian National price target raised to C$148 from C$142 at CIBC
- 03/26/21 Vertical Research
- Canadian National reinstated with a Hold at Vertical Research
- $354.85 /
-10.33 (-2.83%) - 04/15/21
- Fly Intel: Top five analyst upgrades
- 04/15/21 Barclays
- Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
- 04/09/21 Scotiabank
- Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
- 04/06/21 Susquehanna
- Canadian Pacific-KSU deal should clear regulatory hurdles, says Susquehanna
- 16:01 Today Wells Fargo
- Apple events points to faster than expected 'M1 proliferation' says Wells Fargo
- 14:46 Today Wedbush
- New iPads should give Apple another product tailwind, says Wedbush
- 04/19/21 Needham
- Kulicke & Soffa initiated with a Buy at Needham
- 04/19/21 Wedbush
- Wedbush expecting new Apple iPad launches 'with a few surprises' this week
- 04/19/21 Morgan Stanley
- Morgan Stanley reiterates Microsoft as a Top Pick ahead of earnings
- 04/13/21 Morgan Stanley
- Morgan Stanley says Microsoft 'uniquely positioned' for synergies with Nuance
- 04/13/21 Craig-Hallum
- Nuance downgraded to Hold from Buy at Craig-Hallum
- 04/13/21 Wedbush
- Nuance downgraded to Neutral at Wedbush on Microsoft deal
- $13.42 /
-5.955 (-30.74%) - 02/24/21 Piper Sandler
- Kura Oncology price target lowered to $30 from $34 at Piper Sandler
- 02/18/21 B. Riley Securities
- Syndax initiated with Buy, $30 price target at B. Riley
- 02/17/21 B. Riley Securities
- Syndax initiated with a Buy at B. Riley Securities
- 01/29/21 Baird
- Syndax assumed at Outperform at Baird
- $136.22 /
-41.76 (-23.46%) - 03/17/21 Citi
- Futu Holdings price target lowered to $230.30 from $246.50 at Citi
- 02/26/21 Citi
- Futu Holdings price target raised to $246.50 from $119.70 at Citi
- 02/22/21 86 Research
- Futu Holdings downgraded to Hold from Buy at 86 Research
- 02/16/21 Morgan Stanley
- Futu Holdings initiated with an Overweight at Morgan Stanley
- $121.66 /
+6.5302 (+5.67%) - 12:11 Today Chardan
- Amended pact may show Vertex confidence in Crisper program, says Chardan
- 03/17/21 Guggenheim
- Editas Medicine assumed with a Neutral at Guggenheim
- 03/04/21 JMP Securities
- Crispr Therapeutics initiated with an Outperform at JMP Securities
- 03/01/21 Barclays
- Crispr Therapeutics price target raised to $140 from $113 at Barclays
VRTX Vertex Pharmaceuticals - 12:11 Today Chardan
- Amended pact may show Vertex confidence in Crisper program, says Chardan
- 03/25/21 Citi
- Citi likes share setup for Vertex Pharmaceuticals, adds to Focus List
- 02/23/21 Baird
- Baird upgrades Vertex Pharmaceuticals, shares attractive ahead of readouts
- 02/23/21 Baird
- Vertex Pharmaceuticals upgraded to Outperform from Neutral at Baird
- 04/19/21
- IBM says Q2 analyst estimates for revenue look reasonable, consensus $18.23B
- 04/19/21
- IBM sees FY21 revenue growth based on mid-April 2021 forex rates
- 04/19/21
- IBM reports Q1 Cloud & Cognitive Software revenue $5.4B, up 3.8%
- 04/19/21
- IBM reports Q1 adjusted EPS $1.77, consensus $1.63
- 06:37 Today
- Johnson & Johnson raises FY21 adjusted EPS view to $9.30-$9.45 from $9.25-$9.45
- 06:32 Today
- Johnson & Johnson reports Q1 adjusted EPS 2.59, consensus $2.34
- 04/19/21
- Notable companies reporting before tomorrow's open
- 04/19/21
- Notable companies reporting before tomorrow's open
- 06:57 Today
- Travelers reports Q1 core EPS $2.73, consensus $2.37
- 04/19/21
- Notable companies reporting before tomorrow's open
- 04/19/21
- Notable companies reporting before tomorrow's open
- 01/21/21
- Travelers reports Q4 core EPS $4.91, consensus $3.18
- 07:06 Today
- Procter & Gamble backs FY21 core EPS view up 8%-10%, consensus $5.67
- 07:03 Today
- Procter & Gamble reports Q3 EPS $1.26, consensus $1.19
- 04/19/21
- Notable companies reporting before tomorrow's open
- 04/19/21
- Notable companies reporting before tomorrow's open
- 04/19/21
- United Airlines reports Q1 adjusted EPS ($7.50), consensus ($7.05)
- 04/19/21
- Notable companies reporting after market close
- 04/12/21
- United Airlines sees Q1 revenue $3.2B, consensus $3.29B
- 01/20/21
- United Airlines ended 2020 with $19.7B in available liquidity
- $295.55 /
+39.22 (+15.30%) - 04/16/21
- Kansas City Southern reports Q1 EPS $1.68, consensus $1.94
- 01/22/21
- Kansas City Southern sees FY22 EPS $10.50-$11.00
- 01/22/21
- Kansas City Southern sees FY21 EPS at least $9.00, consensus $8.51
- 01/22/21
- Kansas City Southern reports Q4 EPS $1.80, consensus $1.92
- 01/26/21
- Canadian National sees FY21 adjusted EPS up high-single digits
- 01/26/21
- Canadian National reports Q4 adjusted EPS C$1.43 vs. C$1.25 last year
- $354.85 /
-10.33 (-2.83%) - 01/27/21
- Canadian Pacific sees FY21 double-digit adjusted diluted EPS growth
- 01/27/21
- Canadian Pacific reports Q4 adjusted EPS C$5.06 vs. C$4.77 last year
- 04/13/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 01/27/21
- Apple reports Q1 EPS $1.70, consensus $1.41
- 01/27/21
- Notable companies reporting after market close
- 10/29/20
- Apple says Q4 results were ahead of expectations
- 02/16/21
- Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet
- 01/26/21
- Microsoft reports Q2 EPS $2.03, consensus $1.64
- 01/26/21
- Notable companies reporting after market close
- 10/27/20
- Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B
- 03/11/21
- Nano Dimension reports Q4 EPS (20c) vs. (35c) last year
- 02/09/21
- Nano Dimension sees 2020 revenue $3.4M, one est. $2.43M
- 11/12/20
- Nano Dimension reports Q2 EPS (45c), one est. (8c)
- $13.42 /
-5.955 (-30.74%) - 03/08/21
- Syndax reports Q4 EPS (44c), consensus (49c)
- 11/02/20
- Syndax reports Q3 EPS (46c), consensus (44c)
- $121.66 /
+6.5302 (+5.67%) - 02/16/21
- Crispr Therapeutics reports Q4 EPS ($1.50), consensus ($1.27)
- 10/28/20
- Crispr Therapeutics reports Q3 EPS ($1.32), consensus ($1.18)
VRTX Vertex Pharmaceuticals - 02/01/21
- Vertex Pharmaceuticals reports Q4 EPS $2.51, consensus $2.59
- 02/01/21
- Notable companies reporting after market close
- 10/29/20
- Vertex Pharmaceuticals reports Q3 EPS $2.64, consensus $2.34
- 10/29/20
- Notable companies reporting after market close
|